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Abstract 
The ability of pulse oximeters to measure carboxyhemoglobin (HbCO) in blood or measure 
accurate values of oxygen saturation (SpO2) in the presence of elevated levels of HbCO is an 
important advantage because high exposure to carbon monoxide (CO) can be fatal or results in 
permanent neurological damage. The aim of my research was to develop an algorithm that would 
measure SpO2 and SpCO simultaneously using a pulse oximeter. Several specific wavelengths at 
which changes in SpCO and SpO2 can be measured with high sensitivity and specificity were 
identified. The choice of these wavelengths was experimentally verified utilizing an in-vitro set 
up. Preliminary results using our algorithm showed an accuracy of -1.1 to +2.7% [±1.96 SD] for 
SpO2 ranging between 70-100%, and -2 to 3.3% [±1.96 SD] for SpCO ranging between 30% 
with a specificity of 83.3% and a sensitivity of 100% for SpO2 and SpCO, respectively. 
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Chapter 1. Physiological and clinical significance of oxygen and carbon monoxide 
saturation 
1.1. Oxygen saturation and its significance 
Oxygen (O2) is essential to human life. Cells and tissues in the body require oxygen to survive. 
Any reduction in the supply of this vital nutrient causes irreversible cell damage or even death.  
O2 is not particularly soluble in blood [1]. Normally, only about 3% of the total oxygen carried is 
in a dissolved state while about 97% of the oxygen transported to the tissues is carried by 
hemoglobin (Hb). Therefore, Hb is solely responsible for the bulk of O2 transportation to tissues 
[2].  
Hb is an iron-containing protein that is made of amino acids strung together forming 
polypeptide chains. Each hemoglobin molecule consists of a heme component and a globin 
component.  The globin unit is made up of four polypeptide chains.  In commonly occurring 
forms of adult Hb, two of the polypeptide chains are called alpha chains and the other two are 
called beta chains. Each of these chains has one heme group which has an iron atom at the center 
of a porphyrin ring. One polypeptide chain with a heme group is a subunit of Hb. Hb has four 
such subunits, each with an iron atom [3].  These iron atoms in the heme group are the binding 
sites for molecules. Each oxygen molecule combines with one iron atom loosely and reversibly. 
Hence, four O2 molecules can bind to one molecule of Hb [4].  For one polypeptide chain the 
reaction between Hb and O2 can be shown as  
     H    O2  H O2      (1.1) 
Hb with oxygen combined to it is called oxyhemoglobin (HbO2), while Hb without any oxygen 
bound to it is called deoxyhemoglobin or reduced Hb (Hb). Normal human blood contains 15 g 
Hb/ 100 ml blood. Each gram of Hb can bind with about 1.34 ml of O2 resulting in an oxygen 
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capacity of 20ml/100 ml of blood [5].  Oxygen saturation in blood is defined as the fraction of 
Hb molecules that are bound to O2.  Oxygen saturation can be defined in terms of functional 
oxygen saturation or as fractional oxygen saturation. Fractional oxygen saturation is defined as 
the ratio of HbO2 concentration to the total concentration of Hb. Functional oxygen saturation is 
defined as the ratio of HbO2 concentration to the sum of the concentrations of Hb and HbO2. 
Pulse oximeters measure functional oxygen saturation (SpO2) given by Eq. 1.2. 
           
    
       
          (1.2) 
When the oxygen saturation is at 100%, there are no free binding sites available.  
SpO2 measurement is commonly used in anesthesia, neonatology, pediatric care, cardio-
pulmonary resuscitations and intensive care. Using pulse oximeters, desaturation in anesthetized 
patients can be identified in real time before irreversible tissue death occurs. It is especially 
useful in preventing hypoxemia that occurs due to diminished alveolar ventilation during 
anesthesia [6]. Pulse oximeters are also used as a standard diagnostic tool in intensive care and 
emergency room. 
 
1.2. Physiological and clinical effects of CO 
The most important physiological effect of CO exposure is its preferential binding with Hb. The 
binding affinity of CO is ~230 times the affinity O2 has for Hb. Hence, when CO exposure 
occurs, Hb binds preferentially with CO resulting in the formation of carboxyhemoglobin 
(HbCO) [7]. The effect of this preferential binding is the shift in the Hb dissociation curve to the 
left (Fig. 1.1) [8].  
3 
 
 
Fig. 1.1. O2-CO-Hb dissociation curve [7]. 
From Fig. 1.1, at 0% HbCO, in the region between 0-60 mmHg, a large amount of O2 can leave 
the Hb with only a slight decrease in PO2, thus releasing O2 to the cells in the body. On the 
contrary, in the flattened region above 60 mmHg, oxygen saturation is consistently high. This 
enables Hb to bind to O2 in the lungs where PO2 is high [2]. Shifting of the curve to the right 
indicates a decrease in the affinity of Hb to O2, whereas shifting of the curve to the left indicates 
an increase in affinity. In the absence of HbCO, the shifting of the curve to left is due to changes 
in the molecular structure of Hb caused  y Bohr’s effect [4]. As mentioned earlier, in the 
presence of HbCO, the preferential binding of Hb with CO causes the curve to shift to the left. 
Shifting of the curve towards the left, indicating the increase in the affinity of Hb for O2, implies 
that the tissues will have difficulty obtaining O2 from the blood.  Thus, as the concentration of 
HbCO increases and the concentration of HbO2 decreases, cells are deprived of normal oxygen 
delivery resulting in hypoxia. Observations and studies in literature report that 3 parts of CO per 
10,000 parts ambient air will cause fatalities within 20 minutes.  
In a clinical environment, both oxygen and carbon monoxide saturation in blood are 
significant parameters. When CO exposure occurs, pulse oximeters are unable to detect the 
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presence of HbCO and also lose the ability to measure SpO2 accurately. This is an important 
limitation because CO, a colorless, odorless gas, is the leading cause of poisoning deaths in the 
United States. It is believed to be responsible for more than half the poisoning deaths worldwide. 
Around 5000 to 6000 people die every year in the United States alone due to CO exposure. CO 
exposures at home or workplaces can occur due to improper maintenance of heaters, indoor air 
conditioners, gas stoves, and vehicle exhaust. While firefighters are susceptible to CO poisoning 
due to smoke inhalation, army field exposures commonly occur in tanks, troop compartments of 
armored vehicles, enclosed communication vans, indoor testing and firing of weapons [7]. 
Miners are another group of people who are at the risk of CO poisoning. Several accidents 
resulting in fatalities of miners have been reported due to CO exposure, caused by detonations 
and explosions in the confines of a narrow shaft [8]. Due to lack of ventilation, the miners will be 
exposed to high concentrations of CO in within a short span that results in fatalities. There have 
also been reports of CO poisoning cases in houses constructed near old shaft mines [9].   
Apparent health effects of CO exposure is reported to occur at a concentration of approximately 
20% and higher. Early cardiovascular effect caused by CO poisoning is tachycardia in response 
to hypoxia [10-11]. At higher concentrations hypotension, dysrhythmia, ischemia, infarction and 
cases of cardiac arrest have been reported [7]. Therefore, diagnosing CO poisoning before it 
causes severe tissue damage becomes critical. If pulse oximeters could monitor HbCO levels 
noninvasively, patients with CO poisoning may be treated immediately, thus preventing further 
harm. Also, in case of exposure during combat or fire, medics might be able to perform remote 
triage from a safe location without being exposed to CO.  
Diagnosing CO poisoning at early stages is the key because Hb-CO binding is a reversible 
chemical reaction. After dissociating from CO, Hb does not exhibit any impairment in its oxygen 
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carrying capacity [12]. Hence, if patients who have been exposed to CO poisoning can be treated 
immediately, damage to cells and tissues can be prevented.   
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Chapter 2. Background on pulse oximetry 
Pulse oximeters measure SpO2 in blood noninvasively using the time-varying 
photoplethysmographic signal (PPG) caused by variation in the arterial blood volume 
corresponding to the heart beat [13]. When light is passed through the skin, it is absorbed by 
venous blood, tissue, hair, skin pigments, pulsating and non-pulsating arterial blood. During 
systole, when there is more blood in the arteries, there is an increased absorption as the diameter 
of the arteries increase. During diastole, when blood in the arteries is diminished, the light path 
length is decreased and hence the absorption decreases. Thus, light absorption pulsates between 
the maximum and minimum intensity, resulting in a PPG signal as illustrated in Fig. 2.1. The 
absorption of light through the skin, hair and tissues is constant for a given individual and is 
denoted as the DC component.  
 
Fig. 2.1. Light absorption through the skin [13]. 
 
2.1. SpO2 measurement using pulse oximetry 
At wavelengths used in pulse oximetry, Hb and its derivatives are the main absorbers of light in 
blood. The most commonly occurring Hb derivatives are HbO2, HbCO, MetHb and Hb. As 
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shown in Fig. 2.2, in the red region, the absorption of light by Hb is more than the absorption of 
HbO2. Similarly, the absorption of light in the IR region is low for Hb compared to the 
absorption caused by HbO2. Assuming that HbCO and MetHb are absent, SpO2 is measured 
based on the variation in this absorption of light by HbO2 and Hb (Fig. 2.2). Two wavelengths, 
typically from the red and infrared region, are used. The ratios of PPG signals at these two 
wavelengths are used to calculate SpO2 [14]. 
 
Fig. 2.2. Absorption spectra of Hb and its derivatives [14]. 
SpO2 calculation is based on the assumption that HbCO and MetHb are absent. When HbCO 
or MetHb is present in significant quantities, pulse oximeters give erroneous SpO2 readings. 
Apart from the presence of HbCO and MetHb, the variation caused by differences in the 
absorption of light by the skin can also affect the accuracy of pulse oximeters because, 
practically, when light is passed through the skin, the DC component varies between individuals 
and also with wavelengths. This variation also affects the AC component [15-16].  To make the 
AC absorption independent of the DC absorption, a normalization process is applied (Fig. 2.3). 
Accordingly, the absorbance of light is calculated using the normalized signals as given below. 
  Normalized Absorbance=    
(  )  
(  )
     
  
  
     
      ( )  
  
   ( )      (2.1)  
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where, IL is the transmitted intensity during systole and IH is the transmitted intensity during 
diastole [15]. The ratio of the normalized absorbances at the red and infrared wavelength is 
calculated as shown in Eq. 2.2 
    
  
   
 
(
  
   
) 
(
  
  
)  
      (2.2)  
where, AR and  AIR are the normalized red and infrared absorptions, respectively. 
                         
 
 Fig. 2.3. Variation in DC absorption between R and IR wavelengths before (a) and after 
         normalization (b) [14]. 
 
Typically, 660 nm (red) and 940 nm (infrared) are the two wavelengths that are commonly 
used in commercial pulse oximeters to measure SpO2. Absorption ratios are calculated at these 
two wavelengths after the PPG signals are amplified, filtered and undergo signal processing. In 
commercially available pulse oximeters, SpO2 is calculated using an empirical calibration 
conducted based on this ratio. As mentioned earlier, calculation and calibration for SpO2 
measurement using pulse oximeters is based on the assumption that HbCO is absent. Hence, 
during CO exposure the pulse oximeters are unable detect the presence of HbCO in blood. It 
wrongly reads the additional absorption caused by HbCO as the absorption due to HbO2, 
resulting in erroneous computations of SpO2.  
IH  
IL 
 IH  IL
 
 IH  IL
 
 Normalized signals 
Raw signals 
   IH  
IL  
(b)  (a) 
 R   IR  R IR   
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2.2. Current methods available for simultaneous measurement of oxygen and carbon 
monoxide saturation   using pulse oximetry  
So far, only one commercially available pulse oximeter, the Masimo Rad-57 (Masimo Inc., 
Irvine, CA) can measure SpCO and SpO2 simultaneously, but the algorithms used are not 
disclosed. The Masimo Rad-57 uses eight wavelengths, but it measures an additional parameter 
MetHb apart from SpCO and SpO2 [10]. Hence, the number of wavelengths or the exact 
wavelengths used to measure SpCO is not known.  
As mentioned in Chapter 1, firefighters, miners and army personnel are more susceptible to 
CO poisoning. In the modern day warfare, nearly 30% of the soldiers would be deployed using 
armored fighting vehicle (AVF) which not only increases the chances of exposure to CO but also 
increase the levels of exposure. Even development of better ventilation systems has not 
eradicated the risk of CO poisoning in AVFs [12]. Similarly, firefighters and miners are 
constantly exposed to CO in their line of duty [17]. The currently existing Masimo pulse 
oximeter cannot be used for continuous monitoring of firefighter, army personnel or miners as 
they carry on their day-to-day activities. A continuous monitoring system which can monitor 
vital physiological parameters, including HbCO, would enable a clinician or field commanders to 
remotely monitor the health of these individuals and take immediate and appropriate action to 
prevent any harm to health.   
Our lab has developed a wearable wireless pulse oximeter sensor for non-invasive 
monitoring of vital signs that can be used by first responders like firefighters or field medics to 
facilitate rescue and triage operation. The device can be worn around the forehead and is 
designed to transmit the information wirelessly to a remote location [Fig. 2.4]. Firefighters, army 
personnel or first responders can go about their activities with the device strapped around their 
10 
 
forehead. The wireless pulse oximeter sensor developed in our laboratory can measure SpO2, 
heart rate (HR) and respiratory rate (RR). The aim of this thesis was to develop an algorithm that 
can be used in this wireless device to simultaneously measure SpO2 and carbon monoxide 
saturation (SpCO). 
 
Fig. 2.4. Multiwavelength wireless pulse oximeter device designed in our lab. 
Inadequacies of commercial pulse oximeters like low battery life, bulkiness and wires that 
prohibit the use of the device in field applications have been eliminated in our wireless pulse 
oximeter. Hence, if the wireless device can simultaneously measure SpO2 and SpCO, it will find 
additional potential applications not just for firefighters or first responders, but also in clinical 
settings where patient mobility is important.   
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Chapter 3: Specific objectives 
The inability of pulse oximeters to measure HbCO in blood, or measure accurate values of SpO2 
in the presence of elevated levels of HbCO, is an important limitation because high exposure to 
CO can be fatal or result in permanent neurological damage. If pulse oximeters could monitor 
HbCO levels, CO poisoning can be treated immediately, preventing further harm. Therefore, the 
aim of this thesis was to develop an algorithm that could simultaneously measure SpO2 and 
HbCO in blood using a pulse oximeter.  The specific objectives of this thesis were to: 
1. Develop a theoretical model for simultaneous measurement of SpCO and SpO2.  
2. Identify the specific wavelengths at which changes in SpCO and SpO2 can be measured 
simultaneously. 
3. Formulate an algorithm to simultaneously measure SpCO and SpO2 using pulse oximetry. 
4. Verify the algorithm experimentally using an in-vitro set up. 
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Chapter 4. In-vitro model for simultaneous measurement of SpO2 and SpCO  
4.1. Need for an in-vitro model  
Although in-vivo measurements can provide information on the impact of different physiological 
variables, it is not practically possible to desaturate a healthy individual below 80% or elevate 
SpCO above 12% due to safety and ethical considerations as there is a risk of hypoxic brain 
damage to the person at SpO2 values lower than 80% and greater than 12% SpCO.  Hence, it is 
difficult to obtain data from in-vivo measurements at low values of SpO2 or high values of SpCO 
for initial testing of pulse oximeters [16]. Use of animal models for initial testing of pulse 
oximeters is possible. But, results from animal studies have suggested that unknown or 
uncontrollable physiological parameters can cause large variation especially at low SpO2 values 
[18]. Similarly, a study comparing an animal model and in-vivo calibration reports that 
differences in skin structure between humans and animals can also affect the calibration of pulse 
oximeter. Although, piglets are reported to have histologically a skin structure similar to human 
beings, the effect of skin structure on pulse oximeters has not been completely studied [18]. 
Hence, in spite of calibration using animal models, as mentioned in chapter 2, pulse oximeters 
have to be finally calibrated on humans. This is because there is no other accepted standard 
reference for checking the calibration of pulse oximeter [20]. As shown in Fig. 4.1, in-vivo 
calibration for SpO2 requires in-vivo tests on volunteers after they breathe N2 gas to decrease the 
SpO2 in their blood. Similarly, SpCO calibration required subject to breathe CO to elevate the 
concentration of HbCO in the blood. These studies are expensive, time consuming and carry a 
certain risk. Hence, in-vitro measurements using a tissue simulator can be a practical and 
relatively inexpensive method for initial testing and calibration of a new pulse oximeter. 
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Fig. 4.1. In-vivo calibration of a pulse oximeter sensor conducted on a volunteer.  
4.2. Description of in-vitro models 
Various attempts have been made at developing an in-vitro model that simulates the optical 
properties of biological tissues. The interaction of light with tissue is a complicated process. It is 
not practically possible to simulate the interaction of light with tissue to a great detail. Hence, an 
in-vitro model tries to simulate the relevant optical properties of tissue. Typically, an in vitro 
model consists of a flexible cuvette through which the blood is pulsed.  The change in blood 
channel depth as blood is pulsed through creates the pulsatile signals (PPG) that are used to 
calculate the ratios required for SpO2 or SpCO measurement [18]. The true value of oxygen or 
carbon monoxide saturation can be obtained by simultaneous blood sampling in an in-vitro 
analysis using a CO-Oximeter. 
14 
 
 
Fig. 4.2. In-vitro model developed by Reynolds et al. [22]. 
 
The majority of these in-vitro models use a phantom finger that can be inserted between the 
LEDs and the photodiode of a pulse oximeter probe. An in-vitro model developed by Vegfors 
[21] consists of a cylindrical oxygenator which also acts as blood reservoir and a phantom finger 
through which blood was pulsed using a peristaltic pump, thereby simulating a finger containing 
blood surrounded by tissue.  While the model used silicone for the phantom fingers, plastic cubes 
were used to simulate tissues surrounding the blood vessel. Similarly, the system developed by 
Reynolds [22] consists of a phantom finger made of silicone strips through which the blood can 
be pulsed by a computer controlled pump. It also consists of an oxygenator controlled by 
rotameters and a gas mixing pump that is used to control the saturation of the blood (Fig. 4.2).   
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Fig. 4.3. In-vitro model developed by Edrich et al. [18].  
The in-vitro model developed by Edrich et al. [18] also had a similar phantom finger but the 
model had incorporated additional layers to the phantom finger to mimic the biological tissue 
more closely. The cuvette was made of two plexiglass slabs, separated from each other by a 
rubber gasket and flexible membrane, forming two chambers each with separate input and 
output. While blood was pulsed through one of the chambers of the cuvette, homogenized milk 
was circulated through the second chamber. Milk was meant to act as a diffuser to simulate the 
light scattering effect of the bloodless tissue (Fig. 4.3). Oura et al. [23] developed a double –
layered model that simulated both arterial and venous circulation that creates a mock circulatory 
system (Fig 4.4). 
 
                                                                 
 
Fig. 4.4. Mock circulatory system developed by Oura et al. (a). Schematic representation of the 
double layered cuvette (b) [23].  
  
(a)
  
 (b) 
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Although all these in-vitro models mimic the optical properties of biological tissues, they are not 
simple and easy to use. As mentioned earlier, in spite of using such complicated models, a final 
in-vivo calibration has to be conducted on the device. Hence, instead of using models that are 
complicated and difficult to use, a simple in-vitro model that had been designed in our lab was 
used in the experiments [Fig. 4.5]. 
 
Fig. 4.5. Experimental set up (a) and a close up of the blood compartment in the tissue simulator  
    (b). 
 
The in-vitro model that was designed in our lab also has a cuvette through which blood can 
be pulsed through, using a pulsatile pump, similar to the models described above. An oxygenator 
was used to change the O2 or CO content in blood. But, the cuvette was designed for placement 
of a reflectance sensor which consists of the LEDs and the photo detector on the same plane. 
Typically reflectance sensors are placed on the forehead and are not as affected by peripheral 
vasoconstriction as transmission sensors which are placed on fingers. The cuvette in the model 
designed in our lab, could simulate a thin layer of blood between tissues similar to the blood 
layer observed in the forehead. A small white substrate is placed on one side of the cuvette to 
simulate the strong reflection caused by the frontal bones in the forehead. The prototype sensor is 
designed to be used on the forehead. Measurements from other parts of the body, such as the 
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arms or legs are feasible, but typically result in poor signal-to-noise ratio because tissue depth in 
these parts will cause high attenuation which in turn results in poor quality PPG signal.  
 
4.3. Experimental set-up 
Data was collected using the tissue simulator, a pulsatile pump, reflectance type pulse oximeter 
sensor and an oxygenator (Fig.4.5a). The true values of oxygen and carbon monoxide saturation 
was obtained using a IL 682 CO-oximeter. A sensor with seven LED wavelengths between 
600nm to 1000nm that has been previously designed in our laboratory was used in the 
experiments.  The seven wavelengths were chosen for the following reasons: 
1. At wavelengths below 600nm the absorption by the blood and tissue is very high. Above 
1000nm, the absorption by water in the tissue becomes very high. Therefore, the window 
of 600nm to 1000nm was chosen. 
2. Only LEDs of specific wavelengths are available commercially. Although other sources 
(e.g. incandescent light) are available at different wavelengths, they increase the expense 
and complexity of the sensor. 
3. Increasing the number of LEDs will increase the size of the sensor and the complexity of 
the hardware. 
The particular LED’s were chosen such that the wavelengths are approximately dispersed 
evenly as shown in Fig. 4.6. 
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Fig. 4.6. Absorption spectra for Hb and its derivatives. The vertical lines  indicate   
seven wavelengths used in our prototype sensor. 
 
4.4. HbCO measurement using CO-Oximeters 
As mentioned earlier, the true values of HbO2 and HbCO in blood used in experiments was 
obtained using an IL 682 CO-Oximeter. Blood samples drawn from patients can be analyzed in-
vitro by a CO-Oximeter to obtain HbO2, HbCO, Hb and MetHb. CO-Oximeters use four 
wavelengths to measure light transmission based on Beer-Lam ert’s law. It uses a hollow 
cathode lamp as a spectral source to obtain fixed spectral lines at 535nm, 585.2nm, 594.5nm, and 
626.6nm using an optical set up that includes lens, a rotating filter wheel and a beam splitter. The 
coefficients of absorptivity for HbO2, HbCO, Hb and MetHb are obtained at these wavelengths 
and are locked into the digital memory. Absorption values are obtained for all the parameters 
measured after the blood sample is hemolyzed in the instrument. From Fig. 4.7, 535nm and 
594.5nm are isobestic for HbCO and HbO2 and 585.2nm is isobestic for HbO2 and Hb. Using 
Beer- Lam ert’s law, CO-Oximeters simultaneously measure the values of HbCO, HbO2, Hb and 
MetHb using these isobestic wavelengths.   
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 Fig. 4.7. Absorption spectra of Hb, HbCO, HbO2, MetHb in the visible region. 
  The vertical lines indicate the wavelengths used in an IL 682 CO-
oximeter [25]. 
 
Using Beer-Lamberts law, the absorption at the four wavelengths can be generalized as 
Ai=bCj(ε)ij      (4.1) 
where, Ai is the absorption at four wavelengths(i=1-4), b is the sample path length, Cj is the 
concentration of the four Hb species (j=1-4), (ε)ij is the absorptivity or extinction coefficient at 
four wavelengths for the four Hb species. From equation (4.1), the device calculates the 
concentrations of each of the Hb derivatives. Total hemoglobin (THb) is calculated as the sum of 
concentrations of all four Hb derivatives. %HbO2 is calculated using the formula for fractional 
oxygen saturation given by 
      
         
   
    (4.2) 
Similarly %HbCO and %MetHb are calculated using the formula shown in Eq. 4.3 and 4.4,  
           
         
   
     (4.3) 
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    (4.4) 
A microcomputer is used to compute HbO2, HbCO, Hb and MetHb. The device has an accuracy 
of 1% for all the parameters it measures [24]. The wavelengths used in CO-Oximetry are in the 
visible range (500nm-650nm) where absorption by blood is very high (Fig. 4.7). The same 
wavelengths cannot be used in pulse oximeters because the incident light absorbed by the tissue 
and the thickness of blood in the tissues is high in the visible region.  
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Chapter 5: Preliminary research to validate the sensor and in-vitro model 
 
Preliminary experiments were conducted to validate the data collected from our in-vitro model. 
The goals of the preliminary experiments were to verify if the optical properties of blood, with 
varying HbO2 and HbCO, observed from our sensor and model follow the trend suggested by the 
standard absorption plot obtained using the coefficients of absorptivities derived from 
spectrophotometric measurements on human blood as published in the literature [25]. For testing, 
the pulse oximeter probe was attached to the model and HbO2 or HbCO concentrations were 
varied by varying the amount of N2 or CO gas introduced into the set up, respectively. Readings 
from the pulse oximeter were simultaneously obtained with blood sampled using an IL 682 CO-
Oximeter as a reference. The in-vitro testing was repeated at different concentrations of SpO2 
and SpCO.  
5.1. Methodology 
5.1.1. SpO2 experiments 
Since HbO2 in the blood varies according to variation in HbCO, understanding and verifying the 
optical properties of blood with varying concentrations of HbO2 was necessary. HbO2 
concentrations in the blood were varied from 50-100% and the absorption readings 
corresponding to different concentrations were obtained at all wavelengths from the sensor.  
Experiments were repeated thrice and the results were averaged and plotted (Fig. 5.1). These 
averaged results were then compared to the plot obtained using the standard absorptivity values, 
for concentrations similar to the values obtained in the preliminary experiments (Fig. 5.2). When 
results from our in-vitro experiments follow the same general trend observed in human blood, it 
implies that the results that will be obtained for simultaneous measurement of SpO2 and SpCO 
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from our in-vitro set up will follow a general trend that will be observed in in-vivo 
measurements. 
5.1.2. SpCO experiment 
Similarly, preliminary SpCO experiments were performed with the addition of CO to the blood. 
HbCO in the blood was varied from 0-35% and the results are plotted in Fig. 5.3. Similar to the 
SpO2 analysis, the results from our experiments were then compared to the plot obtained using 
the standard absorptivity values found in the literature, at concentrations similar to the values 
obtained in the preliminary experiments (Fig. 5.4).  
 
5.1.3. Assessing the validity of the tissue simulator 
 
In an in-vitro set up, in addition to the optical properties of blood, light absorption and scattering 
is also dependent on the optical properties of the tissue simulator. To validate our tissue 
simulator, a set of experiments were conducted with a commercially available Masimo 
reflectance pulse oximeter. SpO2 levels were varied between 50-100%. The blood was 
simultaneously sampled using the IL 682 CO-oximeter as a reference. The in-vitro model was 
validated by comparing the results from the Masimo pulse oximeter and the true values obtained 
from the IL 682 CO-Oximeter. 
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5.2. Results 
 
Fig.5.1. Mean AC/DC plots obtained from three sets of SpO2 experiments. 
 
 
Fig. 5.2. Absorption spectra of HbO2 obtained from the literature [25]. 
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Fig. 5.3. Mean AC/DC plots obtained for three sets of SpCO experiments. 
 
 
Fig. 5.4. Absorption spectra of HbCO obtained from the literature [25]. 
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5.3. Discussion 
5.3.1. SpO2 experiments 
The results from our SpO2 experiments (Fig. 5.1) were found to follow the same trend suggested 
by Fig. 5.2 which was obtained from hemolysed blood using a collimated, monochromatic light 
source. Results from our experiments, on the contrary, were obtained from an in-vitro model 
using whole blood and a reflectance sensor which uses LEDs that are neither monochromatic nor 
collimated sources. Hence, although the curves from Fig. 5.1 and Fig. 5.2 follow the same trend, 
they are not identical. To check for reproducibility, the mean and standard deviation from three 
SpO2 experiments were calculated and tabled in Table 5.1.   
Table 5.1: AC/DC ratios (mean ±standard deviation) for three sets of experiments with varying 
SpO2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
SpO2 (%) 
Wavelength 
(nm) 
97 - 98.2 84 - 87.6 73.4 - 76.5 
 
     61.7 - 63.7 
 
54.3 - 54.6 
610 2.09 ± 0.00 
 
2.28 ± 0.19 2.44 ± 0.20 2.53 ± 0.19 2.59 ± 0.16 
643 1.51 ± 0.04 
 
1.92 ± 0.19 2.16 ± 0.17 2.31 ± 0.19 2.48 ± 0.23 
660 1.25 ± 0.07 1.72 ± 0.10 1.99 ± 0.11 2.16 ± 0.13 2.35 ± 0.21 
 
740 1.26 ± 0.04 
 
1.42 ± 0.01 1.55 ± 0.01 1.63 ± 0.02 1.73 ± 0.05 
 
830 1.67 ± 0.02 1.65 ± 0.04 1.65 ± 0.03 1.65 ± 0.05 1.63 ± 0.02 
 
880 1.79 ± 0.05 1.74 ± 0.07 1.74 ± 0.07 1.71 ± 0.08 1.69 ± 0.06 
 
940 1.61 ± 0.05 1.59 ± 0.10 1.58 ± 0.08 1.55 ± 0.07 1.53 ± 0.07 
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From Table 5.1, at 610 nm, 643 nm and 660 nm, the absorption by Hb is high for lower values of 
SpO2. This results in a weak signal, thereby, decreasing the signal-to-noise ratio. Hence, the 
variation is higher for low values of SpO2 but low at higher ranges of SpO2. Since the variation 
between the three sets of readings is less than 1% for all the ranges of SpO2 and wavelength 
tested, the results obtained using our sensor and in-vitro model can be considered to be 
reproducible within experimental errors. 
                                                                                                                                             
5.3.2. SpCO experiments 
The results from our SpCO experiments were also found to follow the same trend suggested by 
Fig. 5.4. As mentioned previously, the results from our in-vitro model are not identical to the 
absorption plot obtained from measurements conducted on hemolysed blood (Fig. 5.4). Mean 
and standard deviation between the three SpCO experiments were calculated to check for 
reproducibility.   
Table 5.2: AC/DC ratios (mean ±standard deviation) for three sets of experiments with varying  
SpCO. 
 
SpCO (%) 
Wavelength (nm) 4.4 – 7.7 10.8 – 17.8 17.8 – 21.9 
 
26.6-28.8 
 
31.5-34.6 
610 1.94 ± 0.12 
 
1.92 ± 0.12 1.92 ± 0.11 1.92 ± 0.11 1.91 ± 0.12 
643 1.39 ± 0.10 
 
1.39 ± 0.10 1.39 ± 0.10 1.39 ± 0.09 1.37 ± 0.11 
660 1.13 ± 0.06 1.13 ± 0.06 1.11 ± 0.05 1.09 ± 0.04 1.13 ± 0.11 
 
740 1.15 ± 0.03 
 
1.15 ± 0.03 1.10 ± 0.03 1.01 ± 0.06 1.20 ± 0.02 
 
830 1.57 ± 0.07 1.57 ± 0.07 1.48 ± 0.08 1.38 ± 0.11 1.61 ± 0.05 
 
880 1.69 ± 0.09 1.69 ± 0.09 1.59 ± 0.09 1.51 ± 0.12 1.73 ± 0.08 
 
940 1.54 ± 0.10 1.54 ± 0.10 1.48 ± 0.08 1.42 ± 0.11 1.57 ± 0.09 
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Table 5.2 shows that the standard deviation between the absorption values for three sets of 
experiments is low at all wavelengths and concentration ranges considered. At 610nm, the 
absorption by HbCO is high. This results in a weak signal that decreases the signal-to-noise ratio. 
Hence, the variation is relatively higher for all ranges of SpCO at this wavelength.  The standard 
deviation between the readings is less than 1% for all wavelengths at all ranges of SpCO. Hence, 
these results can be considered to be reproducible within experimental errors. 
5.3.3. Assessing the validity of the tissue simulator 
As mentioned in Section 5.1.3, experiments were conducted using the commercial Masimo pulse 
oximeter on our in-vitro simulator with simultaneous blood sampling using IL 682 CO-
Oximeter. Standard deviation was calculated between IL 682 data and the data from the Masimo 
pulse oximeter obtained from our in-vitro model. The mean standard deviation between the two 
data sets was found to be ±2.9% for SpO2 between 50-100%. This error is acceptable because 
commercially available pulse oximeters are calibrated on humans and not on in-vitro models. 
Thus, the model can be used for the HbCO determination.  
Hence from these preliminary experiments, it is shown that the results obtained from our 
model and our sensor can be used for measurement of both SpO2 and SpCO. 
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Chapter 6: Theoretical modeling for simultaneous measurement of SpO2 and SpCO  
6.1. Need for a theoretical model 
The wavelengths required for accurate monitoring of SpO2 can be identified based on Fig. 2.2. 
Assuming, HbCO is absent, SpO2 measurement involves two unknowns, the concentration of 
HbO2 and Hb. To calculate these two unknowns, we would need a minimum of two wavelengths. 
One wavelength can be chosen from the region of maximum sensitivity to changes in SpO2 and 
the other wavelength can be chosen from an isobestic wavelength region. The ratio of absorption 
at those two wavelengths can be used to calculate SpO2. However, to determine the effect 
different factors would have on SpO2 measurements, like temperature induced changes in LED 
peak wavelengths, time consuming and expensive experiments have to be conducted. 
Alternatively, the sensitivity at different wavelengths can be found using a theoretical model. 
The need for a theoretical model is more pronounced in the case of SpCO measurement because, 
in the presence of HbCO, there are three unknown variables (concentrations of HbO2, Hb and 
HbCO) involved in SpO2 and SpCO measurement. A minimum of three wavelengths are 
required to calculate these variables simultaneously. Identifying experimentally three 
wavelengths that would have good sensitivity to changes in both SpO2 and SpCO solely based on 
Fig. 2.2 will be time consuming and expensive. Hence, a theoretical model becomes a practical 
and effective means to identify the wavelengths for simultaneous measurement of SpO2 and 
SpCO. 
The laws that can be used to obtain a theoretical model should simulate the effects of light 
interaction with  lood and tissue. Twerky’s multiple scattering theory has so far  een the most 
successful for modeling whole blood for in-vitro oximetry [26-27]. Similarly, a model based on 
3-D photon diffusion theory has been used to effectively simulate light propagation through 
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biological tissues [27-28]. However, the mathematical models that are based on these theories 
are more complex. In spite of using these complex theories to model light interaction with blood 
and tissue, a pulse oximeter must be finally calibrated on humans. This is because there is no 
standard to validate the results that will be obtained from these models [29]. Although Beer-
Lamberts law is not applicable to pulse oximetry, the final empirical calibration performed on 
the device based on in-vivo measurements compensates for the simplifications made in the 
theoretical model [30]. Therefore, Beer-Lamberts law was used to develop a theoretical 
formulation to facilitate the development of a simple algorithm for simultaneous measurement of 
SpO2 and SpCO.  
6.2. Beer-Lambert’s Law 
According to Beer-Lam ert’s law, when a monochromatic, collimated light Io is incident on an 
absorbing medium, part of the light is transmitted while the other part is absorbed. It is based on 
the property that the sum of the transmitted and absorbed light intensities are equal to Io. Thus, 
Io will decrease exponentially with distance (Fig. 6.1) [7]. 
 
Fig. 6.1. Exponential decrease in light intensity as it passes through an absorbing  
medium [7]. 
 
According to Beer- Lam ert’s law, the a sorption through a medium (A) is given as 
          (     )   ( )      (6.1) 
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where,     ( ) is the absorptivity for a given wavelength 
    b is the path length 
   c is the concentration of the absorbing substance 
If there are multiple absorbers in the medium, each absorbing substance contributes to the total 
absorbance corresponding to its concentration and absorptivity. Thus, the total absorbance for n 
absorbing substance is  
                           ( )       ( )       ( )        ( )     ∑   
 
   ( )       (6.2) 
 
where,  i ( ) represent the absorptivity, bi represent the path length and ci is the concentration of 
the absorbing substance i, respectively. 
Strictly, Beer-Lam ert’s law does not account for light scattering or specular light reflection 
at the surface of a biological medium. In reflectance pulse oximetry, as in the case of 
transmission mode, the principle quantity measured is the change in light absorption. The 
theoretical model developed based on Beer-Lam ert’s law was used to estimate the relative 
change in the absorption ratio corresponding to the change in SpO2 or SpCO. By quantifying this 
relative change in ratio, the sensitivity of different wavelengths to changes in SpO2 or SpCO can 
be identified. To avoid inaccuracies associated with any attempt to utilize a theoretical 
formulation to describe light propagation through biological tissues and obtain a quantitatively 
accurate algorithm to determine SpO2 or SpCO, commercial pulse oximeters rely on empirical 
calibration [15].  
A study evaluating the relationship between SaO2 and the R/IR ac-dc ratio, used in pulse 
oximeters under a variety of physiological conditions, like different blood volumes, hematocrit, 
pigmentation and finger thickness, show that in pulse oximeters using fixed calibration curves 
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based on empirical measurements, errors introduced by interfering variables should be less than a 
few percent in the clinically significant range of 70-100% [28]. Hence empirical calibration of 
the device has been successfully employed for SpO2 measurement in commercially available 
pulse oximeters. Similarly such calibration can be employed for simultaneous measurement of 
SpO2 and SpCO.     
6.3. Derivation of the theoretical model 
As mentioned in Chapter 2, at wavelengths used in pulse oximetry, Hb and its derivatives are 
the main absorbers of light in blood. The most dominant Hb derivatives are HbO2, Hb, HbCO 
and MetHb. The measurement of SpO2 by a pulse oximeter is based on the assumption that the 
concentration of HbCO or MetHb in blood is negligible. For the purpose of this thesis, we will 
assume that the concentration of MetHb is negligible. The blood that was used in our 
experiments had negligible concentrations of MetHb. Hence, concentrations of HbO2, HbCO 
and Hb are the three unknowns that need to be calculated and hence a minimum of three 
wavelengths were required to calculate these unknowns.  
Literature search on simultaneous measurement of SpCO and SpO2 yielded only two results. 
Lee et al. [31] developed two theoretical models, one based on Beer-Lam ert’s law and the other 
based on photon diffusion theory. Using the theoretical model based on Beer-Lam ert’s law, the 
sensitivity of different combinations of three wavelengths to changes in SpCO and SpO2 were 
determined. The wavelengths used by Lee were reported to be between 600-940 nm.  Then, 
using an in-vitro model which mimics the absorption properties of the tissue, absorption values 
were obtained from blood samples with a known concentration of HbCO and HbO2 at these  
wavelength combinations and the sensitivity of the wavelength ratios to changes in SpO2 and 
SpCO were verified experimentally. The paper reports good accuracy for simultaneous in-vitro 
32 
 
measurement of SpCO and SpO2 at 630 nm, 660 nm and 950 nm, but it does not discuss the 
sensitivity of other wavelength combinations to changes in SpCO and SpO2. Pieralli et al. [32] 
developed a theoretical model for SpO2 and SpCO measurement also based on Beer-Lam ert’s 
law. Three laser diodes (660 nm, 830 nm and 1060 nm) were used in a prototype sensor. The 
paper discusses the results of a series of in-vivo SpO2 and SpCO experiments where SpCO was 
varied from 3.5%-8%. Discrepancies were reported in 3 out of 440 human tests. Since there are 
no LED’s availa le at 1060 nm, the use of laser diodes makes the hardware more complicated, 
bulky and expensive. Hence, the use of this specific wavelength is not practical in a pulse 
oximeter sensor. Although both papers do not discuss the sensitivity of other wavelength 
combinations to changes in SpCO and SpO2, they suggest that the use of a three wavelength 
combination is sufficient for simultaneous measurements of SpCO and SpO2 using pulse 
oximeters. Despite these developments in identifying potential wavelengths, a pulse oximeter 
that would simultaneously measure SpO2 and SpCO was not commercially available until 
Masimo Rad-57 was commercialized. As mentioned previously, a minimum of three 
wavelengths are required to measure SpO2 and SpCO simultaneously. Based on this assumption, 
a theoretical model was be established by applying Beer-Lam ert’s law. 
According to Beer-Lam ert’s law, the total a sor ance for n a sor ing su stances is the sum 
of absorbance of each substance corresponding to its concentration, absorptivity and path length. 
For simultaneous measurement of SpCO and SpO2, the total absorbance for three homogenously 
mixed absorbing substances (HbO2, RHb and HbCO) at each wavelength is given as 
 (  )      (    )      (  )      (    )  (6.3) 
 (  )      (    )      (  )      (    )   (6.4) 
    (  )      (    )      (  )      (    )               (6.5) 
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where,  
a11, a21, a31 are the absorptivities of HbO2, H  and H CO at wavelength  1, respectively,  
a12, a22, a32 are the absorptivities of HbO2, H  and H CO at wavelength  2, respectively, 
a13, a23, a33 are the absorptivities of HbO2, H  and H CO at wavelength  3, respectively, 
 1,  2,  3 are the chosen wavelengths, 
b is the optical path length. 
 
Dividing equations (Eq. 6.3), (Eq. 6.4), (Eq. 6.5) by HbO2, we get 
 (  )
    
           (  )      (  )        (6.6) 
 (  )
    
           (  )      (  )        (6.7) 
 (  )
    
           (  )      (  )        (6.8) 
where, 
c2= Hb/HbO2  
c1= HbCO/HbO2 
 
Let    r1 = 
 (  )
 (  )
   
[        (  )     (  )] 
[        (  )     (  )] 
       (6.9) 
and  r2 =  
 (  )
 (  )
   
[        (  )     (  )] 
[        (  )     (  )] 
       (6.10) 
 
From Eq. 6.9 and Eq. 6.10, we get 
r1 [        (  )      (  )] =          (  )      (  )     (6.11) 
r2 [        (  )      (  )] =          (  )      (  )     (6.12) 
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Grouping the c1 and c2 terms in Eq. 6.11 and Eq. 6.12, 
      (   )     (         )    (          )         (6.13) 
       (   )    (          )   (          )        (6.14) 
 
Simultaneous equations (Eq. 6.13- Eq. 6.14) can be solved for c1 and c2 using Cramer’s rule as 
shown below. 
△      [
(         ) (          )
(          ) (          )
]       (6.15) 
    
 
 
[
(         )       (   )
(          )        (   )
]       (6.16) 
     
 
 
[
      (   ) (          )
       (   ) (          )
]       (6.17) 
 
Solving for △ using Eq. 6.15, 
△ (         )(          )   (          )(          )   
=                                                                                
 
Simplification yields,   
△=   (             )     (             )       (              )  (               )  
=   (             )     (             )  (              )      (6.18) 
 
Solving for    using Eq. 6.16, 
   
 
 
[(         ) (          )   (         )(          )]  
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= 
 
 
[                                                                               ]  
 
Simplification yields,   
  = 
 
 
[   (               )     (              )       (             )   (             )] 
  = 
 
 
[ 
 
(               )     (              )  (             )]    (6.19) 
Solving for    using Eq. 6.17, 
    
 
 
[ (         )(          )   (          )(          )]   
= 
 
  
[                                                                               ] 
 
Simplification yields, 
  = 
 
 
[  (             )     (              )      (               )   (             )] 
  = 
 
 
[  (             )     (              )  (             )]   (6.20) 
 
The formula for SpO2 and SpCO is given by Eq. 6.21 and Eq. 6.22. 
SpO2 = 
[    ]
[    ] [    ] [   ]
 
 
       
       (6.21) 
     
[    ]
[    ] [    ] [   ]
 
  
       
        (6.22) 
 
Substituting the values of △, c1 and c2 in Eq. 6.21,  
     
 
   
 
 
[  (               )    (              )  (             )]
= 
= 
 
  
 
 
[  (             )     (              )  (             )]
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    =  
 
     [  (                )    (               )    (              )] 
= 
           
 
    [  (              )    (               ) (              )]
  
    = 
  (             )     (             )  (              )  
  (                                           )    (                                           )
  
  
  (             )    (             ) (              )
 (                                        
       (6.23) 
 
Eq. 6.23 can be written as 
SpO2 = 
         
         
          (6.24) 
where, 
A=(             ) 
B=(             ) 
C=(              )   
D=(                                           ) 
E=(                                           ) 
F=(                                         ) 
Similarly, substituting for c1, c2 and △, in Eq. 6.22, 
  SpCO= 
[  (        a      )    (              ) (             )]
  (                      a       a            )   (                                           )
  
 = 
[  (        a      )    (              ) (             )]
 (                                        
    (6.25) 
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Eq. 6.25 can be written as shown in Eq. 6.26. 
SpCO = 
       
     
  
            
         (6.26) 
where, 
   (               ) 
   (              ) 
   (             ) 
    (                                           ) 
    (                                           ) 
   (                                         ) 
 
Thus, the values of SpO2 and SpCO when r1= A( 1)/A( 2) and r2= A( 3)/A( 2) can be 
calculated from Eq. 6.24 and Eq. 6.26 using the absorption ratios obtained at desired 
wavelengths. Since, the wavelengths that would have high sensitivity to changes in SpO2 
and SpCO measurements were not known a priory, models were developed for different 
possible ratio as follows.  
r1= A( 1)/A( 2) and r2= A( 1)/A( 3);  
r1= A( 1)/A( 2) and r2= A( 3)/A( 1); 
r1= A( 1)/A( 2) and r2= A( 2)/A( 3). 
The models obtained for these ratios are shown in the table below. 
Table 6.1. Theoretical models derived for different ratio. 
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r1= A(λ1)/A(λ2) and r2= A(λ1)/A(λ3) 
SpO2= 
   (              )    (              )     (              ) 
   (                                            )   (                                            ) 
   
 
   (              )     (              )      (              )
     (                                             )
 
SpCO= 
   (              )    (              )     (              ) 
   (                                            )   (                                            )
  
= 
   (               )     (               )      (               )
      (                                                  )
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 r1= A(λ 1)/A(λ2) and r2= A(λ3)/A(λ1) 
SpO2= 
   (              )   (              )      (              ) 
   (                                            )  (                                            )
  
 
   (              )   (              )      (              )
     (                                             ) 
 
  
SpCO= 
   (              )  (              )     (              ) 
   (                                            ) (                                            ) 
   
 
   (              )   (              )      (              )
     (                                             )
 
r1= A(λ1)/A(λ2) and r2= A(λ2)/A(λ3) 
SpO2= 
  (              )  (              )     (              ) 
   (                                            ) (                                            ) 
   
 
  (              )   (              )      (              )
     (                                             )
 
SpCO= 
  (              )  (              )     (              ) 
   (                                            ) (                                            ) 
   
 
  (              )   (              )      (              )
     (                                             )
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Using these theoretical simulations, wavelength combinations that have high sensitivity to 
changes in both SpO2 and SpCO can be obtained. Using the wavelengths identified by the 
theoretical simulation described above, an algorithm that enables simultaneous measurement of 
SpO2 and SpCO can be obtained. Note that a noninvasive device which can measure SpCO alone 
can be developed. However, at any given point, the derivatives of Hb are in chemical equilibrium 
with each other. Hence, as the concentrations of HbCO decreases, the relative concentration of 
HbO2 increases and vice versa. Therefore, we need a minimum of three wavelengths to measure 
the concentrations of Hb, HbO2 and HbCO in order to calculate SpCO. As shown in Eq. 6.21-
6.22, using these concentrations of Hb, HbO2 and HbCO necessary to calculate SpCO, SpO2 can 
also be calculated. This makes simultaneous measurement of SpCO and SpO2 more 
advantageous commercially because it enables measurement of additional physiological variable 
using these same concentration values.   
6.4. Wavelength ratio selection 
As mentioned previously, in the presence of HbCO, a minimum of three wavelengths are 
required for simultaneous measurement of SpO2 and SpCO. As shown in Fig. 2.1, the absorption 
in the wavelength regions between 600 nm and 660 nm increases with increase in SpCO. 
Between 800 nm to 950 nm, the change in absorption due to changes in SpCO is opposite to the 
effect observed in the 600-660 nm region. Hence, a ratio of two wavelengths, one from the 600-
660 nm region and another from 900-940 nm region will have relatively high sensitivity to 
changes in SpCO. Two wavelengths (660 nm and 940 nm) that have the highest sensitivity to 
changes in SpO2 can be used for simultaneous measurements of SpO2 and SpCO. Apart from 
A660/A940, a second ratio of any wavelengths between 600 - 660 nm as well as 940 nm, will have 
good sensitivity to changes in SpCO. In the sensor used in our lab, there are two LEDs available 
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in this wavelength region, 610 nm and 643 nm. Therefore, r1 will correspond to A660/A940 and r2 
can be A643/A940 or A610/A940. These ratios of r1 and r2 will have high sensitivity to changes in 
SpCO and can be used for simultaneous measurement of SpCO and SpO2. Although both ratios 
of A643/A940 and A610/A940 will have relatively high sensitivity to changes in SpO2, A643/A940 will 
have a higher sensitivity than A610/A940 (Fig. 2.1). Also, the absorption by blood is high around 
600 nm and that can cause a low signal to noise ratio at 610 nm. Hence, r1 = A660/A940 and r2 = 
A643/A940 will have high sensitivity to both SpO2 and SpCO and can be used for simultaneous 
measurement of SpO2 and SpCO. Theoretical simulations were conducted using these 
wavelengths to confirm the above conclusions.  
6.4.1. Validation of the theoretical model for r1= A (660/940) and r2= A (643/940) 
In order to validate the theroretical model, theoretical simulation for SpO2 in the absence of 
HbCO was obtained at r1=660/940 and r2=643/940, by substituting HbCO=0 in Eq. 6.21. When 
HbCO is absent, SpO2 value computed by the three-wavelength model and the two-wavelength 
model (used in commercially available pulse oximeters to measure SpO2 in the absence of 
HbCO) should be approximately the same. Hence, SpO2 calculated from the three wavelength 
model using r1= A(660)/(940) and r2= A(643)/(940) was compared to the results obtained for r1= 
A(660)/(940). It was found that SpO2 calculated from the two and three wavelength model were 
approximately the same when HbCO=0 (Fig. 6.2-6.3). Therefore, these theoretical simulations, 
verified that the sensitivity of 660/940 and 643/940 to changes in SpO2 in the absence of HbCO 
is approximately the same as the sensitivity of 660/940. Hence, the theoretical model was 
validated for use of 660 nm, 643 nm and 940 nm as the primary wavelengths. 
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Fig.6.2. Theoretical simulation for                 Fig. 6.3. Theoretical simulation for %SpO2 
                  %SpO2 at r1= 660/940 and r2=643/940.                (HbCO is absent) using two           
                        wavelengths (r1=660/940). 
                                       
6.5. Theoretical Simulations 
 
SpO2 and SpCO were theoretically calculated by substituting the absorptivities and absorption 
ratios in the model. The absorptivity values corresponding to the wavelengths were obtained 
from the literature [25]. Theoretical absorption ratios for the wavelengths used were 
approximated based on Fig. 2.1. SpO2 and SpCO were calculated by substituting these values in 
the theoretical model. The ratio values were then adjusted to include the clinically significant 
range of 70 to 100% for SpO2 and 0-30% for SpCO. Thus, using the models derived for SpCO 
and SpO2 for different wavelength ratios, the sensitivity of different wavelength combination to 
changes in SpO2 and SpCO were obtained. Five different ratio combinations were obtained from 
each set of wavelengths considered and theoretical simulations were performed for the different 
ratios. This was done to verify that all possible combinations that produce high sensitivity were 
identified. The plots for these theoretical results were generated using Matlab. 
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6.5.1. Simulations for λ= 660, 610 and 940 
 
Fig. 6.4. SpO2 for r1= 660/940 and r2=660/610. 
 
    
Fig. 6.5. SpCO for r1= 660/940 and r2=660/610. 
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Fig. 6.6. SpO2 for r1= 660/940 and r2=660/610. 
 
Fig. 6.7. SpCO for r1= 660/940 and r2=660/610. 
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6.5.2. Simulations for λ= 660, 643 and 940 
 
Fig. 6.8. SpO2 for r1= 660/643 and r2=660/940. 
 
 
Fig. 6.9. SpCO for r1= 660/643 and r2=660/940. 
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Fig. 6.10. SpO2 for r1= 660/940 and r2=643/940. 
 
Fig. 6.11. SpCO for r1= 660/940 and r2=643/940. 
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Fig. 6.12. SpO2 for r1= 660/940 and r2=940/643. 
 
Fig. 6.13. SpCO for r1= 660/940 and r2=940/643. 
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Fig. 6.14. SpO2 for r1= 940/643and r2=940/660. 
 
 
Fig. 6.15. SpCO for r1= 940/643and r2=940/660. 
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Fig. 6.16. SpO2 for r1= 940/660and r2=643/940. 
 
 
 
Fig. 6.17. SpCO for r1= 940/660and r2=643/940. 
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6.5.3. Simulations for λ= 660, 740 and 940 
 
Fig. 6.18. SpO2 for r1= 660/740 and r2=660/940. 
 
 
 
Fig. 6.19. SpCO for r1= 660/740 and r2=660/940. 
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Fig. 6.20. SpO2 for r1= 660/940 and r2=740/940. 
 
 
 
Fig. 6.21. SpCO for r1= 660/940 and r2=740/940. 
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Fig. 6.22. SpO2 for r1= 660/940 and r2=940/740. 
 
 
 
Fig. 6.23. SpCO for r1= 660/940 and r2=940/740. 
 
1.114
1.116
1.118
1.12
1.122
1.124
1.126
1
1.05
1.1
1.15
50
60
70
80
90
100
%
S
p
O
2
1.12 1.121
1.122 1.123
1.124 1.125
1
1.1
1.2
0
5
10
15
20
25
30
%
S
p
C
O
53 
 
 
Fig. 6.24. SpO2 for r1= 940/660 and r2=740/940. 
 
 
 
Fig. 6.25. SpCO for r1= 940/660 and r2=740/940. 
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Fig. 6.26. SpO2 for r1= 940/660 and r2=940/740. 
 
 
 
Fig. 6.27. SpCO for r1= 940/660 and r2=940/740. 
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6.5.4. Simulations for λ= 660, 830 and 940 
 
Fig. 6.28. SpO2 for r1= 660/940 and r2=660/830. 
 
 
Fig. 6.29. SpCO for r1= 660/940 and r2=660/830. 
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Fig. 6.30. SpO2 for r1= 660/940 and r2=830/940. 
 
 
 
Fig. 6.31. SpCO for r1= 660/940 and r2=830/940. 
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Fig. 6.32. SpO2 for r1= 660/940 and r2=940/830. 
 
 
 
Fig. 6.32. SpCO for r1= 660/940 and r2=940/830. 
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Fig. 6.34. SpO2 for r1= 830/940 and r2=940/660. 
 
 
 
Fig. 6.35. SpCO for r1= 830/940 and r2=940/660. 
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Fig. 6.36. SpO2 for r1= 940/660 and r2=940/830.  
 
 
Fig. 6.37. SpCO for r1= 940/660 and r2=940/830.  
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6.5.5. Simulations for λ= 660, 880 and 940 
 
 
Fig. 6.38. SpO2 for r1= 660/880 and r2=660/940.  
 
 
Fig. 6.39. SpCO for r1= 660/880 and r2=660/940.  
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Fig. 6.40. SpO2 for r1= 660/940 and r2=880/940.  
 
 
Fig. 6.41. SpCO for r1= 660/940 and r2=880/940.  
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Fig. 6.42. SpO2 for r1= 660/940 and r2=940/880. 
 
 
Fig. 6.43. SpCO for r1= 660/940 and r2=940/880. 
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Fig. 6.44. SpO2 for r1= 940/660 and r2=880/940. 
 
               
Fig. 6.45. SpCO for r1= 940/660 and r2=880/940. 
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Fig. 6.46. SpO2 for r1= 940/660 and r2=940/880. 
 
Fig. 6.47. SpCO for r1= 940/660 and r2=940/880. 
 
 
 
 
 
 
0.99
0.995
1
1.005
1.01
1.015
1.02
1.025
0.95
1
1.05
1.1
50
60
70
80
90
100
%
S
p
O
2
0.990.995
11.005
1.011.015
0.995
1
1.005
1.01
1.015
0
5
10
15
20
25
30
%
S
p
C
O
65 
 
6.6. Discussion 
Practically, a small change in the value of SpCO will cause a large change in the absorption 
value if the wavelength is sensitive to changes in SpCO. Theoretical simulations confirmed that 
the absorption ratios at 660/940 and 643/940 had the highest sensitivity to changes in SpCO (Fig. 
6.10-6.11). Based on the theoretical results shown previously, Table 6.2 was compiled to 
compare the sensitivities for different wavelength combinations.  The table summerizes the 
differences in the ratio r1 and r2 corresponding to  a 50% decrease in SpO2 and an increase in 
SpCO from 0-30% are calculated. NA in the table indicates those wavelength ratios at which 
SpO2 and SpCO could not be obtained within the clinically significant range.  
From Table 6.2, it was concluded that the absorption at 643/940 and 660/940 had the highest 
relative change in absorption corresponding to changes in SpO2 and SpCO. Therefore, the 
wavelength ratios 660/940 and 643/940 have relatively high sensitivity to changes in SpO2 and 
SpCO as concluded from preliminary experiments.    
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Table 6.2 showing the wavelengths used categorised according to their sensitivity 
Wavelength 
combinations 
Change in SpO2: 50% Change in SpCO: 30% 
Change in r1 Change in r2 Change in r1 Change in r2 
  r1=660/940;r2=610/940 
  r1=660/610;r2=660/940 
r1=660/940;r2=940/610 
r1=940/610;r2=940/660 
r1=940/660;r2=610/940 
NA 
0.0789 
   -0.5089 
NA 
NA 
NA 
-0.0474 
 0.0245 
NA 
NA 
NA 
0.0330 
-0.1080 
NA 
NA 
NA 
      -0.0480 
0.0198 
NA 
NA 
 
r1=660/940;r2=643/940 
r1=660/643;r2=660/940 
r1=660/940;r2=940/643 
r1=940/643;r2=940/660 
r1=940/660;r2=643/940 
 
0.8710 
0.1579 
0.1853 
0.1895 
    -0.4200 
0.7080 
0.0450 
0.0379 
0.0953 
-0.0350 
0.3889 
0.0864 
0.0430 
0.0997 
     -0.2580 
 0.3590 
     -0.0114 
 0.0206 
 0.0499 
 0.0181 
r1=660/940;r2=740/940 
r1=660/740;r2=660/940 
r1=660/940;r2=940/740 
  r1=940/660;r2=740/940 
r1=940/660;r2=940/740 
     -0.0360 
-0.0930 
-0.0050 
 0.0698 
-0.0089 
  0.0030 
     -0.0177 
 -0.0330 
  0.0063 
 -0.0067 
     -0.0640 
     -0.0510 
     -0.0060 
 0.0420 
     -0.0042 
0.0040 
-0.0097 
-0.0340 
 0.0038 
 -0.0430 
 
r1=660/940;r2=830/940 
r1=660/940;r2=660/830  
r1=660/940;r2=940/830 
r1=940/660;r2=830/940 
r1=940/660;r2=940/830 
 
  0.0530 
     -0.0110 
  0.0030 
 -0.0071 
  0.0137 
-0.0166 
-0.0044 
 0.0250 
-0.0171 
 0.0240 
0.0030 
     -0.0188 
0.0020 
     -0.0550 
      0.0076 
0.0096 
     -0.0092 
0.0100 
     -0.0030 
0.0130 
  r1=660/940; r2=880/940 
r1=660/880; r2=660/940 
  r1=660/940;r2=940/880 
  r1=940/660;r2=880/940 
r1=940/660; r2=940/880 
 
   0.0360 
  0.0311 
  0.4510 
  -0.0020 
  0.0240 
 -0.0113 
  0.0105 
  0.0168 
 -0.0163 
  0.0215 
     -0.028 
0.0207 
0.0420 
     -0.0031 
0.0140 
     -0.0123 
      0.0086 
      0.0087 
     -0.0130 
      0.0125 
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6.7. Experimental verification 
 
A series of six in-vitro experiments were conducted in order to verify the theoretical assumptions 
that 643nm, 660nm and 940nm are the most sensitive wavelengths to measure simultaneously 
changes in SpO2 and SpCO. The data from these six experiments were averaged and substituted in 
the respective theoretical model according to the ratios considered. SpO2 and SpCO values 
calculated for these averaged data were plotted against the corresponding ratios as shown below. 
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6.7.1. λ= 660, 610 and 940 
 
Fig. 6.48. SpO2 at r1= 660/940 and r2=660/610 for an average of six experiments. 
 
Fig. 6.49. SpCO at r1= 660/940 and r2=660/610 for an average of six experiments. 
0.55
0.6
0.65
0.7
0.72
0.74
0.76
0.78
56
58
60
62
64
66
68
70
72
%
C
a
lc
u
la
te
d
 S
p
O
2
0.55
0.6
0.65
0.7 0.72 0.74 0.76 0.78
22
24
26
28
30
32
34
36
38
40
%
C
a
lc
u
la
te
d
 S
p
C
O
69 
 
 
Fig. 6.50. SpO2 at r1= 660/940 and r2=940/610 for an average of six experiments. 
 
 
Fig. 6.51. SpCO at r1= 660/940 and r2=940/610 for an average of six experiments. 
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Fig. 6.52. SpO2 at r1= 660/940 and r2=610/940 for an average of six experiments. 
 
 
Fig. 6.53. SpCO at r1= 660/940 and r2=610/940 for an average of six experiments. 
 
 
0.7
0.72
0.74
0.76
0.78 1.1
1.2
1.3
1.4
32
34
36
38
40
%
C
a
lc
u
la
te
d
 S
p
O
2
0.7
0.72
0.74
0.76
0.78
1.151.2
1.251.3
1.35
60
61
62
63
64
65
66
67
%
C
a
lc
u
la
te
d
 S
p
C
O
71 
 
6.7.2. λ= 660, 643 and 940 
 
Fig. 6.54. SpO2 at r1= 660/940 and r2=660/643 for an average of six experiments. 
 
 
Fig. 6.55. SpCO at r1= 660/940 and r2=660/643 for an average of six experiments. 
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Fig. 6.56. SpO2 at r1= 660/940 and r2=643/940 for an average of six experiments. 
 
 
Fig. 6.57. SpCO at r1= 660/940 and r2=643/940 for an average of six experiments. 
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6.7.3. λ= 660, 740 and 940 
 
Fig. 6.58. SpO2 at r1= 660/740 and r2=660/940 for an average of six experiments. 
 
Fig. 6.59. SpCO at r1= 660/740 and r2=660/940 for an average of six experiments. 
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6.7.4. λ= 660, 830 and 940 
 
Fig. 6.60. SpO2 at r1=660/940 and r2=830/740  for an average of six experiments. 
 
 
Fig. 6.61. SpCO at r1=660/940 and r2=830/740  for an average of six experiments. 
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Fig. 6.62. SpO2 at r1=660/940 and r2=660/830  for an average of six experiments. 
 
Fig. 6.63. SpCO at r1=660/940 and r2=660/830  for an average of six experiments. 
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6.7.5. λ= 660, 880 and 940 
 
Fig. 6.64. SpO2 at r1=660/880 and r2=660/940 for an average of six experiments. 
 
 
Fig. 6.65. SpCO at r1=660/880 and r2=660/940 for an average of six experiments. 
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Fig. 6.66. SpO2 at r1=660/940 and r2=880/940 for an average of six experiments. 
 
 
Fig. 6.67. SpCO at r1=660/940 and r2=880/940 for an average of six experiments. 
 
On comparing the SpO2 and SpCO experimental plots obtained at different wavelength ratios 
(Figs. 6.47-6.64),  it was shown that, similar to the theoretical results, changes in SpCO and 
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SpO2 (in the presence of HbCO) causes a relatively larger change in the absorption ratios of 
660/940 and 643/940 (Fig. 6.53-6.54). Hence, from the theoretical and experimental results, it 
was concluded that among the different wavelength ratios considered, absorption ratios at 
660/940 and 643/940 has relatively high sensitivity to SpCO and SpO2. Therefore, 660 nm, 643 
nm, 940 nm were used to simultaneously measure SpO2 and SpCO.  
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Chapter 7. Algorithm for simultaneous measurement of SpO2 and SpCO 
After the specific wavelengths that can be used to measure SpO2 and SpCO have been identified, 
the next step was to formulate the algorithm to differentiate between the presence and absence of 
HbCO in blood.  
To determine HbCO, it is necessary to differentiate between the absorption of blood when 
HbCO is present or absent. Hence, the absorptions obtained by our sensor were analyzed in a 
series of in-vitro experiments. The absorptions values obtained when HbCO was present were 
compared to the absorptions when HbCO was absent. From the results of this comparison, it was 
found that apart from 660 nm, 643 nm and 940 nm, the absorption ratios obtained at 740 nm had 
a significant change in absorption depending on the presence or absence of HbCO. This can be 
explained based on Fig. 2.1, which shows that the absorption in the region between 700 nm to 
750 nm decreases when HbCO is present, while the absorption increases when HbCO is absent. 
Hence, in addition to 660 nm, 643 nm and 940 nm, the absorption at 740 nm was also included in 
the computation to increase the overall selectivity of the device.  
These changes in absorption were used in the algorithm to differentiate between the presence 
and absence of HbCO. A series of 20 in-vitro experiments with elevated HbCO resulted in 
approximately 350 data points at each of the four wavelengths (643 nm, 660 nm, 740 nm, 940 
nm). Similarly, a series of 20 in-vitro experiments conducted in the absence of HbCO resulted in 
approximately 350 data points at each of the four wavelengths. Based on the absorption values 
that were observed from these results, thresholds were set to differentiate between the presence 
and absence of HbCO. These thresholds were incorporated into the algorithm to differentiate 
between the presence or absence of HbCO. 
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7.1. Thresholds used in the algorithm 
The thresholds for r1, r2 and r3 shown in Table 7.1 were incorporated in the algorithm and based 
on the presence or absence of HbCO the algorithm would choose the appropriate formula, 
derived in chapter 6, to calculate SpO2 and SpCO, respectively.  
Table 7.1. Thresholds used in the algorithm to differentiate the presence and absence of HbCO.  
 
r1(A660/940) 
 
 
r2(A643/940) 
 
r3(A740/940) 
 
Present 
 
Absent 
Greater than or 
equal to 1 
 
Greater than or 
equal to 1 
NA SpO2 SpCO 
Greater than 0.84 Greater than 1 Greater than 0.73 SpO2 SpCO 
Greater than 0.54 
and less than 
0.82 
Less than or 
equal to 1.025 
Greater than 0.6 
and less than 
0.82 
SpO2 and SpCO NA 
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Chapter 8. Algorithm to calculate SpO2 and SpCO  
A series of 19 in-vitro SpO2 and SpCO experiments were conducted resulting in 285 and 271 
data points, respectively. The absorption values obtained at 643nm, 660nm, 740nm, and 940 nm 
were averaged and substituted in the algorithm. SpO2 and SpCO calculated by the algorithm 
were plotted against the actual values of SpO2 and SpCO obtained from the IL 682 CO-
Oximeter, respectively. The regression equations obtained for SpO2 and SpCO are shown in Fig. 
8.1 and Fig. 8.4. To validate the regression equations, another series of 5 experiments were 
conducted resulting in 120 and 117 data points for SpO2 and SpCO, respectively.  These data 
points were averaged and then calibrated using the regression line obtained from Fig. 8.1 and 
8.4. The calibrated results were plotted against the actual values obtained from the IL 682 CO-
Oximeter as shown in Fig. 8.2 and 8.5.  Variations in the absorption values were noted, at all 
wavelengths, between different experiments even for the same value of SpCO. To compensate 
for these variations, which were later determined to be caused by changes in light coupling 
between the sensor and tissue simulator, the data points used to calculate and validate the 
regression equation were averaged.  
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8.1. Results 
 
  Fig. 8.1.Calculated SpO2 versus IL 682 HbO2 values. Dashed line is the line of identity. 
               Regression equation: (Calculated SpO2)= 0.4 (IL-682 HbO2) + 50. 
 
 
          Fig. 8.2.Calibrated SpO2 versus IL 682 HbO2 values. Dashed line is the line of      
identity. Regression equation: Calibrated SpO2=0.99*(IL-682 HbO2) +1.1. 
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          Fig. 8.3. Residual plot for data points shown in Fig. 8.2. 
 
 
           Fig. 8.4. Calculated SpCO versus IL 682 HbCO values. Dashed line is the line of identity. 
Regression equation: (Calculated SpCO)= 0.6*(IL 682 HbCO) + 8.4. 
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 Fig. 8.5. Calibrated SpCO versus IL 682 HbCO values. Dashed line is the line of identity. 
Regression equation: (Calibrated SpCO) = (IL 682 HbCO) + 0.28). 
 
 
Fig.8.6. Residual plot for data shown in Fig. 8.5. 
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8.2. Discussion 
Comparing Fig. 8.1 to Fig. 8.2, it is evident that the variation between the calibrated SpO2 and 
IL-682 reference values were much smaller compared to the variation between the calculated 
SpO2 and IL-682 reference readings. Similarly, the variation between the calibrated SpCO and 
IL 682 CO-oximeter readings (Fig. 8.5) was smaller than the variation between the calculated 
SpCO and IL 682 HbCO (Fig. 8.4). From Fig. 8.1 and Fig. 8.2, it is also evident that the 
variations observed between individual experiments, indicated by the error bars, were 
approximately 3% for SpO2 before calibration, but was smaller for the calibrated SpO2 values. 
From Fig. 8.4 and 8.5, it was observed that the variations between individual experiments were 
more pronounced in SpCO experiments, at approximately 6%, for both calculated and 
calibrated values. 
Results from SpCO experiments were analyzed to determine if blood hematocrit (HCT) 
levels caused the variations observed between the experiments. It was observed that calculated 
values from two SpCO experiments with the same HCT level at approximately 30% had a 
standard deviation of ± 2% and ± 7%, respectively. Similarly, it was also observed that results 
from another set of two SpCO experiments with different HCT levels at approximately 40% and 
30% had a similar standard deviation of ± 2.9% and ± 3.1%, respectively. Hence, it was 
concluded that changes in HCT levels did not have a significant effect on the results. Hence, 
steady state SpCO experiments were conducted to determine if changes in light coupling caused 
large variations between the SpCO obtained from different experiments. These experiments were 
conducted by maintaining HbCO level at a steady state value. Other variables like the blood 
hematocrit were also held constant and readings from our sensor were obtained along with 
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simultaneous sampling using the IL 682 CO-Oximeter. The sensor position was changed four 
times during the experiment and 5 readings were taken at each position for comparison.  
 From Table 8.1 and 8.2, it is clear that, the changes in light coupling between the sensor and 
the simulator did contribute to variations between the experiments although the variations within 
each set were small. The variations between the mean SpCO values obtained at different sensor 
position for the same value of HbCO were approximately 7.4%.  
 
Table 8.1. Calculated SpCO corresponding to steady state HbCO at 26.3-27.1% obtained at four  
different sensor positions. 
 
Position 1 
 
Position 2 Position  3 Position 4 
30.5 22.1 22.1 33.7 
31.0 17.6 18.6 32.2 
30.8 21.6 17.1 38.6 
33.4 21.1 17.0 35.9 
30.8 21.8 17.1 37.6 
                                                                          
 
Table 8.2. Mean and standard deviation between the calculated values for SpCO at different 
sensor positions. 
 
 
 
 
Position 1 
(%) 
 
 
 
Position 2 
(%) 
 
 
Position 3 
(%) 
 
 
Position 4 
(%) 
 
Mean 
(%) 
 
 
26.7 
 
Standard 
deviation 
(%) 
 
7.4 Mean 31.2 20.8 18.4 35.6 
 
Standard 
deviation 
 
1.1 1.8 2.1 2.6 
Coefficient 
of 
variation 
3.5 8.6 11.4 7.3   
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Similar steady-state experiments were conducted for different ranges of SpCO. Even at lower 
ranges of SpCO, the data from different experiments had a variation of approximately 7%. 
These were approximately the same variations that were observed between the calculated and 
calibrated SpCO readings.  Hence, it was concluded that changes in light coupling between the 
sensor and the tissue simulator did affect the in-vitro readings. When the sensor is placed too 
close to the model, the amount of light that reaches the blood will be large and will result in 
larger absorption values which would affect the ratios. Similarly, if the sensor is placed far from 
the tissue simulator, the light that reaches the blood will be relatively small and cause a 
corresponding decrease in absorption. Such increase or decrease in absorption will cause a 
corresponding change in the ratio values computed thereby affecting the SpCO values computed. 
The effect that these variations, observed in-vitro, will have on in-vivo measurements is not 
clear. In-vivo, the maximum ratio of blood volume to tissue is estimated to be approximately 5% 
[28, 33]. Hence, only a very small fraction of the incident light reaches the blood. In contrast, in 
our in-vitro model, the blood to tissue is ratio is relatively much higher and can be estimated to 
be more than approximately 80%. Hence, most of the incident light in the model reaches the 
blood compartment. Therefore, sensor positions that may not affect pulse oximeters in-vivo can 
have a more pronounced effect on the readings obtained in-vitro. The ultimate effect of this 
factor can be assessed only after conducting extensive in-vivo tests.  
After identifying the cause of variation between the individual experiments, the calibrated 
data for both SpO2 and SpCO were used to the plot of mean difference between the Il 682 CO-
Oximeter values and the calibrated data. The mean of difference between the IL-682 CO-
oximeter HbO2 and calibrated SpO2 ±1.96 SD were computed and plotted in Fig. 8.3. Similarly, 
Fig. 8.6 compares the mean difference between the HbCO measured IL-682 CO-oximeter and 
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calibrated % SpCO ±1.96 SD values. A SD value of ±1.96 was chosen because 95% of the 
readings will fall within this range. In the absence of HbCO, 95% of the readings fell within 2.7 
to -1.1 for SpO2 between 70-100% (Fig. 8.3). From Fig. 8.6, 95% of the readings fell within a 
variation of 3.3 to -2 % for SpCO between 0-30%. The plot of mean against difference was used 
because, Bland et al. [34] reports that the commonly used plot of difference against reference 
value would give misleading results. The paper shows that, in cases where there is no association 
between the magnitude of the reference and difference between the test and reference values, the 
commonly used plot of difference against reference values will give a positive correlation 
whereas, the plot of difference against the test measurement will show a negative correlation for 
the same case. Hence, any of these plots can be misleading as the association shown between the 
test and reference device will depend on the method of analysis. Hence, the study shows that the 
plot of difference versus the mean of the reference and test measurement as a better way of 
determining the agreement between two device measurements. The results from our SpCO 
experiments (Fig. 8.6) were compared to the accuracy reported by the Masimo Rad-57 pulse 
oximeter which reports an accuracy of ±3% (±1 SD) for SpCO between 0-45 % [35].  
The specificity and sensitivity of the results were then calculated and tabulated as shown 
below in Table 8.3-8.4. Sensitivity is a measure of probability of the test correctly identifying a 
person with disease and specificity is a measure of probability of the test correctly identifying a 
person who does not have a disease. Sensitivity and specificity are given by Eq. 8.1-8.2. 
 
Sensitivity= No. of true positives/ (No. of true positives + No. of false negatives)    (8.1) 
 
Specificity= No. of true negatives/ (No. of true negatives + No. of false positives)    (8.2) 
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where, true positives are cases the device correctly identifies a disease; 
            true negatives are cases the device correctly identifies a lack of disease; 
false positives are the cases the device wrongly identifies a healthy person as having a 
disease; 
false negatives are the cases the device fails to identify a disease and wrongly identifies a 
person with a disease as being healthy [36].  
In our case, sensitivity would mean the probability of the device correctly detecting CO 
poisoning and specificity is the ability of the device to correctly identify persons who do not 
suffer from CO poisoning.  For the calculation of SpO2 sensitivity and specificity for, 90% was 
considered the threshold for mild hypoxia [37]. In case of SpCO, 12% was considered as the 
threshold for calculating specificity and sensitivity because the treatment for carbon monoxide 
poisoning is the same for values of SpCO less than 12%. Concentration of SpCO higher than 
12% requires specific treatment like 100% oxygen therapy [38].   
        Table 8.3. Performance characteristics for SpO2 measurements obtained from the in-vitro 
model and our sensor using our algorithm. 
 
SpO2 
 
Laboratory 
value 
<90  
 
Laboratory  
value 
 >90 
 
Total 
 
Negative 
Test 
 
Positive 
Test 
 
Specificity 
 
 
 
 
 
83.3% 
 
Sensitivity 
 
 
 
 
 
100% 
 
 
 
 
Tissue 
simulator 
<90  
 
9 
 
1 
 
10 
True 
negative 
5 
 
 
False 
negative 
0 
True 
positive 
9 
 
 
False 
positive 
1 
Tissue 
simulator 
>90 
 
0 
 
5 
 
5 
 
Total 
 
9 
 
6 
 
15 
 
 
In the experiments we conducted, SpO2 in blood was less than 90% in nine readings and the 
algorithm correctly identified all nine cases. Hence, in Table 8.3, the number of true positives is 
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9. Similarly, the algorithm correctly identified five cases where SpO2 was greater than 90%. So, 
the number of false negatives in Table 8.3 is 5. But, the algorithm wrongly identified one reading 
as being less than 90%, which requires treatment, when the actual SpO2 was greater than 90%. 
So, the false positive is 1. There were no cases when the algorithm wrongly identified the values 
as being greater than 90% when it was actually less than 90%. Hence, the false negative in Table 
8.3 is 0. Using these values specificity and sensitivity was calculated from the formula shown in 
Eq. 8.1 and 8.2.  
 
        Table 8.4. Performance characteristics for SpCO measurements obtained from  the in-vitro 
model and our sensor using our algorithm. 
 
SpCO 
 
Laboratory 
value 
>12 
 
Laboratory  
value 
<12 
 
Total 
 
Negative 
test 
 
Positive 
Test 
 
Specificity 
 
 
 
 
 
83.3% 
 
Sensitivity 
 
 
 
 
 
100% 
 
 
Tissue 
simulator 
>12 
 
9 
 
1 
 
10 
 
True 
negative 
5 
 
False 
Negative 
0 
True 
positive 
9 
 
False 
positive 
1 
Tissue 
simulator 
<12 
 
0 
 
5 
 
5 
 
 
Total 
 
9 
 
6 
 
15 
 
 
In the experiments we conducted, SpCO in blood was greater than 12% in nine readings and the 
algorithm correctly identified all nine cases. Hence, in Table 8.4, the number of true positives is 
9. Similarly, the algorithm correctly identified five cases where SpCO was less than 12%. So, the 
number of false negatives in Table 8.4 is 5. But, the algorithm wrongly identified one reading as 
being greater than 12%, which requires treatment, when the actual SpCO was greater than 12%. 
So, the false positive is 1. There were no cases when the algorithm wrongly identified the SpCO 
value as being less than 12% when it was actually greater than 12%. Hence, the false negative in 
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Table 8.4 is 0. Using these values specificity and sensitivity was calculated from the formula 
shown in Eq. 8.1 and 8.2.  
As summarized in Tables 8.3 and 8.4, SpCO and SpO2 measurements obtained from our 
senor in-vitro have high sensitivity, thereby ensuring that patients with carbon monoxide 
poisoning will be correctly identified. Although the specificity was slightly lower and lead to few 
false positives, 83% of the data were correctly identified. The results obtained from our 
experiments were compared with the results of the Masimo Rad-57 pulse oximeter published in 
the literature as shown in Table 8.5.  
Table 8.5. Comparison of SpCO with HbCO measured by a CO-Oximeter [39]. 
 
 
 
Author 
 
 
Year 
 
 
Setting 
 
 
No. of 
subjects 
Limits of 
agreement for 
SpCO vs 
HbCO 
(%) 
 
 
Bias (%) 
 
Mottram et al 
 
2005 
 
Respiratory Dept. 
 
31 
 
-1.5 to +5.5 
 
2.0 
 
Barker et al 
 
2006 
 
Laboratory 
 
10 
 
-5.5 to +3.1 
 
-1.2 
 
Coulange et al 
 
2008 
 
Emergency Dept. 
 
12 
 
-6.4 to +3.4 
 
-1.5 
 
Suner et al 
 
2008 
 
Emergency 
 
64 
 
-2.8 to +5.6 
 
-4.2 
 
Kot et al 
 
2008 
 
Hyperbaric 
chamber 
 
49 
 
-7.9 to +8.9 
 
0.5 
 
Piatkowski et al 
 
2009 
 
Burn center 
 
20 
 
-1.5 to +7.8 
 
3.2 
 
Tougher et al 
 
2010 
 
Emergency 
 
120 
 
-11.6 to +14.4 
 
1.4 
 
Our in-vitro-tissue 
simulator 
 
2011 
 
Laboratory 
 
15 
 
-2 to +3.3 
 
-0.7 
 
 
Although, it was shown from table 8.5, that the accuracy range obtained from our in-vitro model 
is close to the accuracy ranges reported by Masimo, the results reported by Masimo were 
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obtained in-vivo whereas our results were obtained from an in-vitro model. Various 
physiological parameters like skin color, amount of tissue, vasoconstriction that were not 
simulated in our in-vitro model may affect in-vivo measurements. Similarly, factors that are more 
pronounced in the model may or may not affect in-vivo measurements. Hence, the results 
obtained from our model cannot be ascertained without further in-vivo verifications. Conducting 
human studies to simultaneously calculate SpO2 and SpCO using our algorithm is a part of future 
work. This would involve identifying the factors that affect the measurement of SpCO and SpO2 
in-vivo and compensating for those variations in order to produce accurate in-vivo measurements 
using a pulse oximeter. 
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Chapter 9. Conclusions and future work  
Measurement of vital physiological conditions from patients is important to provide effective 
triage and medical care in the field. Developments in remote non-invasive monitoring of 
physiological parameters could provide a possibility of immediate medical care for firefighters, 
army personnel and other people working in dangerous environment. SpCO measurement using 
a wireless wearable pulse oximeter that measures SpO2, HR and RR would have a significant 
advantage and could find potential applications for people who are exposed to CO in their line of 
duty. Pulse oximeters are unable to detect HbCO in blood and give erroneous SpO2 values in the 
presence of HbCO. This research therefore, was aimed at developing an algorithm for 
simultaneous measurement of SpO2 and SpCO using a wireless wearable pulse oximeter 
developed in our laboratory.  
To simultaneously measure SpO2 and SpCO, a minimum of three wavelengths were required 
since it involves computing three unknown variables which includes the concentration of HbO2, 
HbCO and Hb. From the absorption spectra of Hb and its derivatives at wavelengths between 
600 nm and 1000 nm, several specific wavelengths at which changes in SpO2 and SpCO can be 
measured with relatively high sensitivity and specificity were identified. Based on the 
availability of LEDs used in the prototype sensor developed in our laboratory, a set of three 
wavelengths (643 nm, 660 nm, 940 nm) were identified. To verify this choice of wavelengths, a 
theoretical model was developed using the Beer-Lam ert’s law. From theoretical simulations, it 
was found that absorption ratios of 660 nm/940 nm and 643 nm/940 nm can be used for 
simultaneous measurement of SpO2 and SpCO with relatively high sensitivity. Additionally, an 
algorithm was formulated to calculate SpO2 and SpCO simultaneously. Hence, based on the in-
vitro experiments conducted, in addition to 660 nm, 643 nm and 940 nm, absorption at 740 nm 
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was also included to increase the selectivity of the device. Based on a series of in-vitro 
preliminary experiments, in addition to 660 nm, 643 nm, and 940 nm, the absorption at 740 nm 
was included to increase the selectivity of the device. Based on the results of the in- vitro 
experiments, thresholds for the absorption ratios at 660/940. 643/940 and 740/940 were 
incorporated to differentiate the presence and absence of HbCO. The last objective of the thesis 
was to verify this algorithm using in-vitro experimental results. From a series of in-vitro 
experiments conducted, SpO2 and SpCO were calculated using the algorithm. The preliminary 
results from our device reports an accuracy of 2.7 to -1.1 for 70-100% SpO2 and 3.3 to -2 % for 
0-30% SpCO with a specificity of 83.3% and a sensitivity of 100% for both SpO2 and SpCO, 
respectively.  
Although the performance characteristics obtained from the in-vitro measurements are within 
the clinically acceptable range, we observed variations in SpCO between the experiments. This 
was identified to be caused by changes in the coupling of light between the optical reflectance 
sensor and the in vitro tissue simulator. The effect that these variations will have on in-vivo 
measurements is not clear. Hence, the algorithm developed in-vitro will need to be evaluated in-
vivo by conducting human validation studies. This would involve identifying the factors that 
could potentially affect in-vivo measurement of SpCO and SpO2 and compensate for those 
variations in order to produce accurate measurements using a wearable pulse oximeter. 
In a clinical setting, monitoring of SpO2 is vital for following physiological trends during 
surgical procedures, post surgery, in emergency rooms and in intensive care units. On the 
contrary, the ability to measure SpCO is more vital for spot checking to diagnose CO poisoning 
rather than to monitor a trend. Typically, the presence of SpCO at values greater than 25% can 
cause permanent neurological damage. The Masimo Rad 57 pulse oximeter measures SpCO with 
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an accuracy of 3% (1SD). Hence, 1.96 SD which would include 95% of the measurements will 
have an accuracy of approximately 6%. Although this is not a high accuracy value, the 
indication of HbCO in blood will enable screening of patients with CO poisoning and enable 
clinicians to decide on an appropriate course of action. Hence, from a clinical standpoint, spot 
checking for SpCO is more critical than the need to monitor the trend in SpCO measurement. 
Although, results from our algorithm using data points obtained from an in-vitro simulator have 
been shown to have an accuracy of 2.7 to -1.1, variations up to 7% have been observed due to 
changes in the coupling of light between the sensor and the simulator. If the coupling of light 
between the sensor and the skin is not found to affect the readings in-vivo, and if we can identify 
and compensate for other factors that could potentially affect SpCO measurement in-vivo, then 
the accuracy rate that can be obtained from our algorithm can potentially be better than the 
accuracy of currently available devices.   
In-vivo testing of our algorithm can be done in the future similar to the in-vivo testing reported 
by Tougher et al. [39] in trauma and burn center of a hospital. People suspected of CO poisoning 
were tested using the Masimo device with simultaneous blood sampling using a CO-Oximeter 
(Siemens Rapidlab 1200 blood gas analyzer) to obtain the true HbCO values. The results from 
both the methods were then compared to assess the accuracy of the Masimo Rad 57 pulse 
oximeter. Testing can also be conducted in a laboratory setting using volunteers breathing safe 
levels of SpCO. Testing of the Masimo pulse oximeter reported by Barker et al. [40] was 
conducted in a laboratory where 10 volunteers breathed 500 ppm of CO until HbCO levels 
reached 15%. As the readings from the Masimo device was obtained, blood samples from arterial 
cannulas were obtained simultaneously to test for true HbCO values. The readings from the two 
devices were compared to establish the accuracy of the Masimo Rad 57 oximeter. 
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Appendix A: Bandwidth of wavelengths used in our prototype sensor 
 
 
Fig. A1. Bandwidth of the wavelengths used in our prototype sensor.  
 
 Table A1: Full width at half maximum for wavelengths used in our prototype sensor 
Data 
(nm) 
Max 
(nm) 
FWHM 
(nm) 
940b 940 59 
880 888 73 
830 823  32 (40) 
740 739 30 
660 660 22 
643 641 20 
610 618 16 
575 576 15 
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Appendix B: Flowchart for the algorithm used for SpO2 and SpCO determination 
 
 
 
 
 
 
 
 
 
Calculate the ratios r 1 = 660/940, r 2 = 643/940, r 3 = 740/940  
Is ((r 1 >= 1)  
&  
(r 2 >= 1))  
Calculate SpO 2 
Yes 
No 
Enter the absorption  values at  
643nm, 660nm, 940nm, 740nm  
Start 
Is((r 1 >0.84  
& r 2 >1)  &  
(r 3 >0.73))     
No Is  
(( r 1 > 0.54)  
&(r 2 <=1.02 
5))  
Yes 
Calculate  
SpCO 
Yes 
Calculate SpO 2 
No 
Is(r 1 <0.82 )  
& ( r 2 <0.6)  
& (r 3 < 0.82) 
Yes 
Calculate SpCO 
   Stop 
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